Skip to main content

ExeFen-DMX Side Effects

Generic name: dextromethorphan / guaifenesin / pseudoephedrine

Medically reviewed by Drugs.com. Last updated on Jun 10, 2024.

Note: This document provides detailed information about ExeFen-DMX Side Effects associated with dextromethorphan / guaifenesin / pseudoephedrine. Some dosage forms listed on this page may not apply specifically to the brand name ExeFen-DMX.

Applies to dextromethorphan / guaifenesin / pseudoephedrine: oral liquid, oral tablet, oral tablet extended release.

Important warnings This medicine can cause some serious health issues

Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using this medication and call your doctor at once if you have:

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to dextromethorphan/guaifenesin/pseudoephedrine: oral capsule, oral liquid, oral suspension, oral suspension extended release, oral syrup, oral tablet, oral tablet extended release.

General

The manufacturer has not provided adverse event information.[Ref]

References

1. (2019) "Product Information. Pecgen PSE (dextromethorphan / guaifenesin / pseudoephedrine)." KramerNovis

More about ExeFen-DMX (dextromethorphan / guaifenesin / pseudoephedrine)

Patient resources

Other brands

Capmist DM, Tusnel, Despec DM, Trispec PSE, ... +7 more

Related treatment guides

Further information

ExeFen-DMX side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.